Product Development Stories

<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;;'>BI</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Biomerica Enterprise Value is projected to increase significantly based on the last few years of reporting. The past year's Enterprise Value was at 83.23 Million. The current year Invested Capital is expected to grow to about 10.6 M, whereas Average Assets are forecasted to decline to about 9.5 M. As many baby boomers are still indifferent towards healthcare space, it makes sense to go over Biomerica. We will cover the possibilities of making Biomerica into a steady grower in February. In this post, I will also go over a few different drivers affecting Biomerica's products and services, and explain how it may impact Biomerica investors.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#689CFD;color: #ffffff;font-size:0.9em;;'>FUB</div>
  over a week ago at Macroaxis 
By Achuva Shats
Fubotv Debt to Equity Ratio is quite stable at the moment as compared to the past year. The company's current value of Debt to Equity Ratio is estimated at 0.90. Free Cash Flow per Share is expected to rise to 0.09 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (15.3 M). As many investors are getting excited about communication services space, it is fair to outline Fubotv Inc. We will evaluate why recent Fubotv price moves suggest a bounce in February. Here I will also expose some primary fundamental factors affecting Fubotv's services, and outline how it will impact the outlook for investors this year.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;;'>EI</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
EXFO Inc Working Capital is quite stable at the moment as compared to the past year. The company's current value of Working Capital is estimated at 32.53 Million. Asset Turnover is expected to rise to 1.07 this year, although the value of Average Assets will most likely fall to about 254.7 M. As many investors are getting excited about technology space, it is fair to outline EXFO Inc Subordinate. We will analyze why it could be a much better year for EXFO Inc shareholders. In this post, I will also go over some essential variables affecting EXFO Inc's products, and show how it may impact EXFO Inc outlook for active traders this year.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#000000;color: #f2f2f2;font-size:0.9em;;'>AZZ</div>
  over a week ago at Macroaxis 
By Ellen Johnson
AZZ Return on Investment is fairly stable at the moment as compared to the past year. AZZ reported Return on Investment of 13.40 in 2020. Quick Ratio is likely to rise to 1.01 in 2021, whereas Revenue Per Employee is likely to drop slightly above 212.5 K in 2021. While some of us are becoming more passionate about industrials space, it makes sense to break down AZZ Inc in greater detail. We will evaluate why we are still optimistic in anticipation of a recovery. In this post, I will also go over a few different drivers affecting AZZ's products and services, and explain how it may impact AZZ investors.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;;'>CM</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Commercial Metals Net Income Per Employee is projected to increase significantly based on the last few years of reporting. The past year's Net Income Per Employee was at 22,206.6. The current year Revenue Per Employee is expected to grow to about 648.1 K, whereas Average Assets are forecasted to decline to about 3.3 B. Today we will go over Commercial Metals. We will evaluate if Commercial Metals shares are reasonably priced going into February. Here I will also go over some technical and fundamental indicators that Commercial Metals investors should consider in February.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;;'>AD</div>
  over two weeks ago at Macroaxis 
By Achuva Shats
Applied DNA Current Ratio is quite stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 2.66. Debt to Equity Ratio is expected to rise to 1.22 this year, although the value of Average Assets will most likely fall to about 11.2 M. While many traders today are more concerned about the preservation of capital over market returns, Applied DNA Sciences could be one exception. We will evaluate why we are still optimistic in anticipation of a recovery. This post is to show some fundamental factors affecting Applied DNA's products and services. I will also disclose how it may impact the investing outlook for the firm in February.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;;'>AC</div>
  over two weeks ago at Macroaxis 
By Raphi Shpitalnik
Akerna Corp Net Cash Flow or Change in Cash and Cash Equivalents is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow or Change in Cash and Cash Equivalents is estimated at 2.7 Million. Issuance Purchase of Equity Shares is expected to rise to about 5.5 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (13.9 M). As some conservative investors are getting more into healthcare space, Akerna Corp Cl could be a your radar. I will take a closer look at this stock and the latest sentiment generated by institutional investors. Here I will also outline some basic indicators that Akerna Corp investors should consider in February.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;;'>SU</div>
  over two weeks ago at Macroaxis 
By Ellen Johnson
In this post, we will focus on Sunworks. We will evaluate if Sunworks shares are reasonably priced going into February. Here I will also expose some primary fundamental factors affecting Sunworks' services, and outline how it will impact the outlook for investors this year.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:0.9em;;'>GEE</div>
  over two weeks ago at Macroaxis 
By Ellen Johnson
GEE Average Assets are projected to increase significantly based on the last few years of reporting. The past year's Average Assets were at 142.63 Million. The current year Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to grow to about 6.7 M, whereas Earnings before Tax are forecasted to decline to (12.7 M). As many of us are excited about industrials space, it is fair to go over GEE Group. We will evaluate if GEE shares are reasonably priced going into February. This post is to show some fundamental factors affecting GEE's products and services. I will also drop some light on how it may impact the investing outlook for GEE in February.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;;'>HO</div>
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
Helen Of Debt to Equity Ratio is projected to increase slightly based on the last few years of reporting. The past year's Debt to Equity Ratio was at 0.73. The current year Return on Sales is expected to grow to 0.1, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are forecasted to decline to about 229.9 M. While many traders today are more concerned about the preservation of capital over market returns, Helen Of Troy could be one exception. We will evaluate why we are still optimistic in anticipation of a recovery. In this post, I will also go over some essential variables affecting Helen Of's products, and show how it may impact the firm outlook for active traders this year.